cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.12917426.v1
title: Wolbachia lycaenids nexus

description: This is a supplementary dataset for manuscript by Suchackova Bartonova et al.: Wolbachia affects mitochondrial population structure in two systems of closely related Palaearctic blue butterflies
DOI: 10.6084/m9.figshare.12917426
title: Wolbachia lycaenids nexus

description: This is a supplementary dataset for manuscript by Suchackova Bartonova et al.: Wolbachia affects mitochondrial population structure in two systems of closely related Palaearctic blue butterflies
DOI: 10.6084/m9.figshare.3467915
title: What can ancient scripts tell us about sound symbolism? (Conference Poster)

description: <b>Styles SJ (2014)</b>. 'What can ancient scripts tell us about sound symbolism?' Poster presented at IMRF in June 2014, Amsterdam.<br><br><b>Summary. </b>Do English-speakers encode sound/shape symbolism for ‘i’ and ‘u’ because of the shape of the letter-forms? Or do languages adopt writing systems which encode salient patterns of sound/shape symbolism? This paper looks to writing systems from across human history to disentangle the direction of causation, by asking whether writing systems visually communicate salient phonological contrasts like /i/ vs /u/. Stimuli were pairs of written letters representing the phonemes /i/ and /u/ in 56 different writing systems from across the globe, throughout human history. All scripts from ‘The World’s Writing Systems’ (Daniels & Bright, eds, 1996) were included if it was possible to represent /i/ and /u/ in isolation. Exclusions were duplicate letter forms and scripts from the Phoenician family (including Greek, Latin, Runic and Cyrillic), with its familiar ‘I’ and ‘U’ shapes. The scripts range from Cuneiform and Mayan hieroglyphs at the earliest, through Devanagari, Ethiopic and Sineform scripts, to Tibetan, Arabic, Hebrew, and modern scripts like Korean Hankul.<br><br><b>Results.</b> When asked which letter in each /i//u/ pair was which, participants consistently performed above chance (accuracy: M=60%, SD=6%; p&gt;.001). This finding indicates that across human history, writing systems have been better-than-chance at conveying a highly salient speech contrast. While many of the scripts were not matched systematically, more scripts were consistently matched correctly (9), than incorrectly (3). Analysis of the consistently matched stimuli reveals which visual features of a written letter are most predictive of contemporary sound/shape mappings: complexity (i-simple/u-complex), curvature (i-tight/u-loose), angularity (i-accute/u-obtuse), or vertical position of detail (i-high/u-low).
DOI: 10.6084/m9.figshare.3467906
title: A chemical view of analogue drug laws in Australia: what is structural similarity?

description: After specific rules establishing whether a molecule is a ‘structural modification’ of a drug molecule, the analogue drug provisions in the various Acts legislated by States and the Commonwealth of Australia rely on rules that determine if a putative drug is ‘structurally similar’ to a dangerous or controlled drug listed by the Act. In some legislation there is a provision for a suitable expert to assert that the two structures are similar. A survey of more than 200 research chemists at UNSW Australia, who are not usually involved in legal matters, asked them to state whether six pairs of molecules were structurally similar or not. There is some correlation with Tanimoto similarity, a measure of similarity often used in pharmaceutical drug discovery, but the use of such an objective measure is not advocated at this time. The concepts of addition of groups, and of replacement of ring structures are discussed in the light of cases and of chemical and general definitions. Regularising the law with chemical understanding and practice is strongly recommended. As similar laws have been enacted in other countries, the conclusions reached here will have interest in jurisdictions outside Australia.
DOI: 10.6084/m9.figshare.3467906.v1
title: A chemical view of analogue drug laws in Australia: what is structural similarity?

description: After specific rules establishing whether a molecule is a ‘structural modification’ of a drug molecule, the analogue drug provisions in the various Acts legislated by States and the Commonwealth of Australia rely on rules that determine if a putative drug is ‘structurally similar’ to a dangerous or controlled drug listed by the Act. In some legislation there is a provision for a suitable expert to assert that the two structures are similar. A survey of more than 200 research chemists at UNSW Australia, who are not usually involved in legal matters, asked them to state whether six pairs of molecules were structurally similar or not. There is some correlation with Tanimoto similarity, a measure of similarity often used in pharmaceutical drug discovery, but the use of such an objective measure is not advocated at this time. The concepts of addition of groups, and of replacement of ring structures are discussed in the light of cases and of chemical and general definitions. Regularising the law with chemical understanding and practice is strongly recommended. As similar laws have been enacted in other countries, the conclusions reached here will have interest in jurisdictions outside Australia.
DOI: 10.6084/m9.figshare.3467903
title: Interventions to tackle malnutrition and its risk factors in children living in slums: a scoping review

description: <b>Context:</b> Children living in slums are at high risk of being malnourished. There are no published reviews on existing interventions promoting better nutrition for children living in slums and the risk factors for children’s malnutrition. Improved understanding of the risk factors for malnutrition in slums communities and the impact of interventions on children’s health can provide guidance to practitioners and decision-makers. The present review is designed to provide this information. <b>Methods:</b> The search included 30 electronic bibliographic databases and relevant eligible studies published up to December 2013. <b>Results:</b> The search located 1512 citations. Full text relevance screening was conducted on 226 studies and on abstracts for 16 studies. The final 58 unique studies included 22 on interventions and 38 on risk. All of the interventions were nutrition-specific, with nutritional intervention being the most dominant type. Seventy-three per cent of the interventions were assessed effective. <b>Conclusion:</b> The findings stressed the gaps in knowledge in terms of quality assessment and programmatic recommendations to identify children who are the most at risk of malnutrition to appropriately target interventions. Finally, the review helped to inform a systematic review (Cochrane Systematic review protocol 2015) that will examine the impact of interventions on outcome measures.
DOI: 10.6084/m9.figshare.3467903.v2
title: Interventions to tackle malnutrition and its risk factors in children living in slums: a scoping review

description: <b>Context:</b> Children living in slums are at high risk of being malnourished. There are no published reviews on existing interventions promoting better nutrition for children living in slums and the risk factors for children’s malnutrition. Improved understanding of the risk factors for malnutrition in slums communities and the impact of interventions on children’s health can provide guidance to practitioners and decision-makers. The present review is designed to provide this information. <b>Methods:</b> The search included 30 electronic bibliographic databases and relevant eligible studies published up to December 2013. <b>Results:</b> The search located 1512 citations. Full text relevance screening was conducted on 226 studies and on abstracts for 16 studies. The final 58 unique studies included 22 on interventions and 38 on risk. All of the interventions were nutrition-specific, with nutritional intervention being the most dominant type. Seventy-three per cent of the interventions were assessed effective. <b>Conclusion:</b> The findings stressed the gaps in knowledge in terms of quality assessment and programmatic recommendations to identify children who are the most at risk of malnutrition to appropriately target interventions. Finally, the review helped to inform a systematic review (Cochrane Systematic review protocol 2015) that will examine the impact of interventions on outcome measures.
DOI: 10.6084/m9.figshare.3467897
title: Data from: Intramolecular transformation of an antifungal antibiotic nystatin A1 into its isomer, iso-nystatin A1. Structural and molecular modeling studies

description: Nystatin A<sub>1</sub>, a polyene macrolide antifungal antibiotic, in a slightly basic or acidic solution undergoes an intramolecular transformation, yielding a structural isomer, the translactonisation product, <i>iso</i>-nystatin A<sub>1</sub> with lactone ring diminished by two carbon atoms. Structural evidence is provided by advanced NMR and MS studies. Molecular dynamics simulations and quantum mechanics calculations gave the insight into the course and mechanism of the transformation and its effect on the conformation of the subject molecule.<br>
DOI: 10.6084/m9.figshare.3467897.v1
title: Data from: Intramolecular transformation of an antifungal antibiotic nystatin A1 into its isomer, iso-nystatin A1. Structural and molecular modeling studies

description: Nystatin A<sub>1</sub>, a polyene macrolide antifungal antibiotic, in a slightly basic or acidic solution undergoes an intramolecular transformation, yielding a structural isomer, the translactonisation product, <i>iso</i>-nystatin A<sub>1</sub> with lactone ring diminished by two carbon atoms. Structural evidence is provided by advanced NMR and MS studies. Molecular dynamics simulations and quantum mechanics calculations gave the insight into the course and mechanism of the transformation and its effect on the conformation of the subject molecule.<br>
DOI: 10.6084/m9.figshare.3467840
title: Comparing Dislodgeable 2,4-D Residues Across Athletic Field Turfgrass Species and Timeitem

description: A data set generated by Matthew Jeffries and Dr. Travis Gannon at North Carolina State University regarding effects of turfgrass species and sampling time on dislodgeable 2,4-D residues on soccer fields. Data were submitted for publication in PLOS One.
DOI: 10.6084/m9.figshare.3467840.v2
title: Comparing Dislodgeable 2,4-D Residues Across Athletic Field Turfgrass Species and Timeitem

description: A data set generated by Matthew Jeffries and Dr. Travis Gannon at North Carolina State University regarding effects of turfgrass species and sampling time on dislodgeable 2,4-D residues on soccer fields. Data were submitted for publication in PLOS One.
DOI: 10.6084/m9.figshare.3467840.v1
title: New draft Comparing Dislodgeable 2,4-D Residues Across Athletic Field Turfgrass Species and Timeitem

description: A data set generated by Matthew Jeffries and Dr. Travis Gannon at North Carolina State University regarding effects of turfgrass species and sampling time on dislodgeable 2,4-D residues on soccer fields. Data were submitted for publication in PLOS One.
DOI: 10.6084/m9.figshare.3467801
title: Subtidal sea star SSWD May-August 2014

description: Prevalence in strip transect located in San Juan Islands for 3 species of subtidal sea stars in from May to August 2014
DOI: 10.6084/m9.figshare.3467771
title: PLA2 proteins FASTA file

description: This is a fasta file of venom PLA2 protein sequences.
DOI: 10.6084/m9.figshare.3467771.v1
title: PLA2 proteins FASTA file

description: This is a fasta file of venom PLA2 protein sequences.
DOI: 10.6084/m9.figshare.3467768
title: Alignment of PLA2 proteins

description: This is the alignment of venom PLA2 proteins. Used in Figure S4.<br>
DOI: 10.6084/m9.figshare.3467759
title: Newick tree of PLA2 proteins

description: This is the newick tree of the venom PLA2 proteins that corresponds to Figure S4.
DOI: 10.6084/m9.figshare.3467756
title: PLA2 proteins and sequences

description: This file consists of the new gene identifiers and published gene identifiers (plus sequences) that were aligned and used to generate a phylogeny of venom PLA2 proteins.
DOI: 10.6084/m9.figshare.3467756.v1
title: PLA2 proteins and sequences

description: This file consists of the new gene identifiers and published gene identifiers (plus sequences) that were aligned and used to generate a phylogeny of venom PLA2 proteins.
DOI: 10.6084/m9.figshare.3467753
title: Subtidal sea star species density 2014 -2015 San Juan Islands

description: Csv containing the results per species per transect in terms of density of subtidal species. Used in the bayesian model of the paper 'Transboundary devastating effects of SSWD in subtidal species.
DOI: 10.6084/m9.figshare.3467747.v1
title: Domestication influences choice behavior and performance of a generalist herbivore

description: Supplemental Data set for <i>Perspective in</i> <i>Plant Ecology, Evolution</i> <i>and Systematics</i> Paper: Domestication influences choice behavior and performance of a generalist herbivore xls-File: Associational resistance experiment: raw data of <i>G. raimondii </i>assoc. resistance experiment<br> FeedingChoiceAssay: raw data containing all collected data concerning the feeding choice of <i>S. littoralis</i> larvae<br> OlfactometerChoiceAssay: raw data containing all collected data concerning the choice of <i>S. littoralis</i> larvae in an olfactometerOvipositionChoiceAssay: raw data containing all collected data concerning the choice of <i>S. littoralis</i> females in an oviposition assay<br><br>PerformanceAssayLarvae: raw data containing all collected data concerning the performance of <i>S. littoralis</i> larvae on different cotton plants<br><br>VolatileRelease: raw data containing all collected concerning the volatile release of different cotton plants over 24h<br>
DOI: 10.6084/m9.figshare.3467741
title: F-Free Benchmarks

description: Graphen so zu modifizieren, dass sie gewisse induzierte Teilgraphen nicht mehr enthalten, ist bis auf gewisse triviale Fälle NP-Vollständig. In dieser Arbeit erarbeiten wir schnelle Annäherungen und testen diese auf ihre Güte.
DOI: 10.6084/m9.figshare.3467741.v1
title: F-Free Benchmarks

description: Graphen so zu modifizieren, dass sie gewisse induzierte Teilgraphen nicht mehr enthalten, ist bis auf gewisse triviale Fälle NP-Vollständig. In dieser Arbeit erarbeiten wir schnelle Annäherungen und testen diese auf ihre Güte.
DOI: 10.6084/m9.figshare.3467711
title: Self-centeredness, selflessness and happiness: data2016

description: Data of the paper titled "Self-Centeredness and Selflessness: Happiness Correlates and Mediating Psychological Processes"Study 1 and study 2.<br>
DOI: 10.6084/m9.figshare.3467711.v1
title: SSHM_data_2016

description: Data of the paper titled "Self-Centeredness and Selflessness: Happiness Correlates and Mediating Psychological Processes"Study 1 and study 2.<br>
DOI: 10.6084/m9.figshare.3467711.v2
title: SSHM_data_2016

description: Data of the paper titled "Self-Centeredness and Selflessness: Happiness Correlates and Mediating Psychological Processes"Study 1 and study 2.<br>
DOI: 10.6084/m9.figshare.3467540
title: Calculation of PI Exploring Mathematics with Your Computer p 213.rtf

description: This is a list of the first 500 terms of pi. The problem was taken from a book by Arthur Engel, Exploring Mathematics With Your Computer.
DOI: 10.6084/m9.figshare.3467540.v1
title: Calculation of PI Exploring Mathematics with Your Computer p 213.rtf

description: This is a list of the first 500 terms of pi. The problem was taken from a book by Arthur Engel, Exploring Mathematics With Your Computer.
DOI: 10.6084/m9.figshare.3467510
title: The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes

description: <b>Objective:</b> To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro three times daily (TID) as add-on therapy when glycemic control is sub-optimal with titrated basal insulin glargine and metformin. <b>Methods:</b> The analysis was based on the recent 4B Study, which compared exenatide BID and lispro TID as add-on therapies in subjects with type 2 diabetes insufficiently controlled, despite titrated insulin glargine. The Cardiff Diabetes Model was used to simulate patient costs and health benefits beyond the 4B Study. The Swedish healthcare perspective was adopted for this analysis; costs are reported in €EUR to aid interpretation. The main outcome measure was the cost per quality-adjusted life-year (QALY) gained with exenatide BID compared to lispro TID. <b>Results:</b> Exenatide BID was associated with an incremental cost of €1,270 and a QALY increase of +0.64 compared with lispro TID over 40 years. The cost per QALY gained with exenatide BID compared with lispro TID was €1,971, which is within conventional limits of cost-effectiveness. Cost-effectiveness results were generally robust to alternative assumptions and values for key model parameters. <b>Limitations:</b> Extrapolation of trial data over the longer term can be influenced by modeling and parameter uncertainty. Cost-effectiveness results were generally insensitive to alternative values of key model input parameters and across scenarios. <b>Conclusions:</b> The addition of exenatide BID rather than insulin lispro to basal insulin is associated with similar or better clinical outcomes. Illustrated from the Swedish healthcare perspective, analysis with the Cardiff Diabetes Model demonstrated that exenatide BID represents a cost-effective treatment alternative to lispro TID as add-on therapy in type 2 diabetes patients insufficiently controlled on basal insulin.
DOI: 10.6084/m9.figshare.3467510.v2
title: The cost-effectiveness of exenatide twice daily (BID) vs insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes

description: <b>Objective:</b> To evaluate the cost-effectiveness of exenatide twice daily (BID) vs bolus insulin lispro three times daily (TID) as add-on therapy when glycemic control is sub-optimal with titrated basal insulin glargine and metformin. <b>Methods:</b> The analysis was based on the recent 4B Study, which compared exenatide BID and lispro TID as add-on therapies in subjects with type 2 diabetes insufficiently controlled, despite titrated insulin glargine. The Cardiff Diabetes Model was used to simulate patient costs and health benefits beyond the 4B Study. The Swedish healthcare perspective was adopted for this analysis; costs are reported in €EUR to aid interpretation. The main outcome measure was the cost per quality-adjusted life-year (QALY) gained with exenatide BID compared to lispro TID. <b>Results:</b> Exenatide BID was associated with an incremental cost of €1,270 and a QALY increase of +0.64 compared with lispro TID over 40 years. The cost per QALY gained with exenatide BID compared with lispro TID was €1,971, which is within conventional limits of cost-effectiveness. Cost-effectiveness results were generally robust to alternative assumptions and values for key model parameters. <b>Limitations:</b> Extrapolation of trial data over the longer term can be influenced by modeling and parameter uncertainty. Cost-effectiveness results were generally insensitive to alternative values of key model input parameters and across scenarios. <b>Conclusions:</b> The addition of exenatide BID rather than insulin lispro to basal insulin is associated with similar or better clinical outcomes. Illustrated from the Swedish healthcare perspective, analysis with the Cardiff Diabetes Model demonstrated that exenatide BID represents a cost-effective treatment alternative to lispro TID as add-on therapy in type 2 diabetes patients insufficiently controlled on basal insulin.
DOI: 10.6084/m9.figshare.3467510.v1
title: The cost-effectiveness of exenatide twice daily (BID) versus insulin lispro three times daily (TID) as add-on therapy to titrated insulin glargine in patients with type 2 diabetes

description: <b>Objective:</b> To evaluate the cost-effectiveness of exenatide twice daily (BID) versus bolus insulin lispro three times daily (TID) as add-on therapy when glycemic control is suboptimal with titrated basal insulin glargine and metformin. <b>Methods:</b> The analysis was based on the recent 4B Study, which compared exenatide BID and lispro TID as add-on therapies in subjects with type 2 diabetes insufficiently controlled despite titrated insulin glargine. The Cardiff Diabetes Model was used to simulate patient costs and health benefits beyond the 4B Study. The Swedish healthcare perspective was adopted for this analysis; costs are reported in €EUR to aid interpretation. The main outcome measure was the cost per quality-adjusted life-year (QALY) gained with exenatide BID compared to lispro TID. <b>Results:</b> Exenatide BID was associated with an incremental cost of €1,270 and a QALY increase of +0.64 compared with lispro TID over 40 years. The cost per QALY gained with exenatide BID compared with lispro TID was €1,971, which is within conventional limits of cost-effectiveness. Cost-effectiveness results were generally robust to alternative assumptions and values for key model parameters. <b>Limitations:</b> Extrapolation of trial data over the longer term can be influenced by modelling and parameter uncertainty. Cost-effectiveness results were generally insensitive to alternative values of key model input parameters and across scenarios. <b>Conclusions:</b> The addition of exenatide BID rather than insulin lispro to basal insulin is associated with similar or better clinical outcomes. Illustrated from the Swedish healthcare perspective, analysis with the Cardiff Diabetes Model demonstrated that exenatide BID represents a cost-effective treatment alternative to lispro TID as add-on therapy in type 2 diabetes patients insufficiently controlled on basal insulin.
DOI: 10.6084/m9.figshare.3467417
title: Rapid and recent diversification of curassows, guans, and chachalacas (Galliformes: Cracidae) out of Mesoamerica: phylogeny inferred from mitochondrial, intron, and ultraconserved element sequences: Cracids complete alignment

description: All mtDNA, intron, and UCE sequences. Nexus format, partitioned.<br>
DOI: 10.6084/m9.figshare.3467417.v2
title: Rapid and recent diversification of curassows, guans, and chachalacas (Galliformes: Cracidae) out of Mesoamerica: phylogeny inferred from mitochondrial, intron, and ultraconserved element sequences: Cracids complete alignment

description: All mtDNA, intron, and UCE sequences. Nexus format, partitioned.<br>
DOI: 10.6084/m9.figshare.3467417.v1
title: Cracids complete alignment

description: All mtDNA, intron, and UCE sequences. Nexus format, partitioned.<br>
DOI: 10.6084/m9.figshare.3467414
title: Rapid and recent diversification of curassows, guans, and chachalacas (Galliformes: Cracidae) out of Mesoamerica: phylogeny inferred from mitochondrial, intron, and ultraconserved element sequences: Cracid UCE alignment

description: UCE alignment, 430 loci. Nexus format, partitioned.<br>
DOI: 10.6084/m9.figshare.3467414.v2
title: Rapid and recent diversification of curassows, guans, and chachalacas (Galliformes: Cracidae) out of Mesoamerica: phylogeny inferred from mitochondrial, intron, and ultraconserved element sequences: Cracid UCE alignment

description: UCE alignment, 430 loci. Nexus format, partitioned.<br>
DOI: 10.6084/m9.figshare.3467414.v1
title: Cracid UCE alignment

description: UCE alignment, 430 loci. Nexus format, partitioned.<br>
DOI: 10.6084/m9.figshare.3467402
title: Rapid and recent diversification of curassows, guans, and chachalacas (Galliformes: Cracidae) out of Mesoamerica: phylogeny inferred from mitochondrial, intron, and ultraconserved element sequences: Cracid UCE contigs

description: Ultraconserved element (Faircloth et al. 2012) contigs assembled with Trinity. Raw data is served on NCBI SRA.<br>